Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

ADC Therapeutics (ADCT) Amortization - Deferred Charges (2019 - 2023)

ADC Therapeutics has reported Amortization - Deferred Charges over the past 5 years, most recently at -$12.9 million for Q3 2023.

  • Quarterly results put Amortization - Deferred Charges at -$12.9 million for Q3 2023, down 13.97% from a year ago — trailing twelve months through Sep 2023 was -$28.8 million (up 1.99% YoY), and the annual figure for FY2022 was $36733.0, up 102.75%.
  • Amortization - Deferred Charges reached -$12.9 million in Q3 2023 per ADCT's latest filing, up from -$15.9 million in the prior quarter.
  • Across five years, Amortization - Deferred Charges topped out at $10291.0 in Q1 2023 and bottomed at -$2.0 billion in Q4 2020.
  • Median Amortization - Deferred Charges over the past 5 years was -$1.4 million (2020), compared with a mean of -$117.5 million.
  • The largest annual shift saw Amortization - Deferred Charges plummeted 4013725390.2% in 2020 before it surged 104.72% in 2021.
  • Over 5 years, Amortization - Deferred Charges stood at -$51.0 in 2019, then tumbled by 4013725390.2% to -$2.0 billion in 2020, then skyrocketed by 100.0% to -$9520.0 in 2021, then dropped by 2.98% to -$9804.0 in 2022, then plummeted by 131907.34% to -$12.9 million in 2023.
  • Business Quant data shows Amortization - Deferred Charges for ADCT at -$12.9 million in Q3 2023, -$15.9 million in Q2 2023, and $10291.0 in Q1 2023.